Bayesian analysis unravels pancreas-cancer adjuvant therapy

Affiliations

¹ Cancer Research UK Liverpool Cancer Trials Unit, Liverpool Cancer Research UK Centre, University of Liverpool, Liverpool, UK; NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, Liverpool, L69 3GA, UK. Electronic address: j.p.neoptolemos@liverpool.ac.uk.
² Cancer Research UK Liverpool Cancer Trials Unit, Liverpool Cancer Research UK Centre, University of Liverpool, Liverpool, UK; NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, Liverpool, L69 3GA, UK.

Comment

John P Neoptolemos et al. Lancet Oncol. 2013 Oct.

. 2013 Oct;14(11):1034-1035.

doi: 10.1016/S1470-2045(13)70403-0. Epub 2013 Sep 12.

¹ Cancer Research UK Liverpool Cancer Trials Unit, Liverpool Cancer Research UK Centre, University of Liverpool, Liverpool, UK; NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, Liverpool, L69 3GA, UK. Electronic address: j.p.neoptolemos@liverpool.ac.uk.
² Cancer Research UK Liverpool Cancer Trials Unit, Liverpool Cancer Research UK Centre, University of Liverpool, Liverpool, UK; NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, Liverpool, L69 3GA, UK.

No abstract available

Comment on

Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis.
Liao WC, Chien KL, Lin YL, Wu MS, Lin JT, Wang HP, Tu YK. Liao WC, et al. Lancet Oncol. 2013 Oct;14(11):1095-1103. doi: 10.1016/S1470-2045(13)70388-7. Epub 2013 Sep 12. Lancet Oncol. 2013. PMID: 24035532